10x Genomics, Inc.
NASDAQ:TXG
22.08 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 618.727 | 516.409 | 490.49 | 298.845 | 245.893 | 146.313 | 71.085 |
| Kosten van de omzet
| 209.414 | 120.386 | 74.091 | 58.468 | 61.033 | 28.661 | 10.56 |
| Brutowinst
| 409.313 | 396.023 | 416.399 | 240.377 | 184.86 | 117.652 | 60.525 |
| Brutowinstmarge
| 0.662 | 0.767 | 0.849 | 0.804 | 0.752 | 0.804 | 0.851 |
| Onderzoek- en ontwikkelingskosten
| 270.332 | 265.667 | 211.752 | 123.375 | 83.097 | 47.537 | 32.164 |
| Algemene en administratieve kosten
| 337.549 | 294.6 | 252.86 | 200.426 | 129.334 | 87.236 | 46.536 |
| Verkoop- en marketingkosten
| 3.3 | 3.7 | 4.7 | 1.9 | 1.5 | 0.7 | 0.2 |
| Verkoop-, algemene en administratieve kosten
| 340.849 | 298.3 | 257.56 | 202.326 | 130.834 | 87.936 | 46.736 |
| Overige kosten
| -0.307 | -0.198 | -0.802 | 1.337 | -0.186 | -0.249 | 0.137 |
| Bedrijfskosten
| 611.181 | 563.967 | 469.312 | 325.701 | 213.931 | 135.473 | 78.9 |
| Bedrijfsresultaat
| -201.868 | -167.944 | -52.913 | -85.324 | -29.071 | -110.764 | -18.375 |
| Bedrijfsresultaat ratio
| -0.326 | -0.325 | -0.108 | -0.286 | -0.118 | -0.757 | -0.258 |
| Totaal overige inkomsten en kosten netto
| -46.895 | 5.973 | -0.802 | -449.152 | -1.962 | -93.192 | 0.137 |
| Inkomen voor belasting
| -248.763 | -161.971 | -53.715 | -534.476 | -31.033 | -112.398 | -18.741 |
| Inkomen voor belasting ratio
| -0.402 | -0.314 | -0.11 | -1.788 | -0.126 | -0.768 | -0.264 |
| Belastingkosten
| 6.336 | 4.029 | 4.508 | 8.255 | 0.218 | 0.087 | 0.021 |
| Nettowinst
| -255.099 | -166 | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Nettowinstmarge
| -0.412 | -0.321 | -0.119 | -1.816 | -0.127 | -0.769 | -0.264 |
| WPA (Winst Per Aandeel)
| -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
| Verwaterde WPA
| -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
| EBITDA
| -158.249 | -161.495 | -53.509 | -82.455 | -26.452 | -13.141 | -13.625 |
| EBITDA ratio
| -0.256 | -0.313 | -0.109 | -0.276 | -0.108 | -0.09 | -0.192 |